Industry Portals
Medical Device Industry News
Integer a velit nec risus malesuada imperdiet id et odio. Nunc sit amet mauris dapibus, feugiat diam eget, suscipit, nam gravida nulla eget turpis commodo.
![pexels-cottonbro-3944377](https://www.youngandpartners.com/wp/wp/wp-content/uploads/2021/02/pexels-cottonbro-3944377-scaled.jpg)
Pharma and Biotech Markets (Young & Partners article in Pharma Executive eBook) Sept 2017
Young & Partners examines the biopharma stock market and M&A trends and their implications
Fire and Ice – Chemical Mergers and Acquisitions- Young & Partners (ICIS Chemical Business Sept 1 -7, 2017 issue)
While the M&A dollar volume is hot, a look behind the numbers shows that not everything is, or will be
Calm Before The Storm – Young & Partners (ICIS Chemical Business May 19 – 25, 2017 issue)
First Quarter M&A volume was modest, but we are heading for a monster year in M&A in terms of dollar volume
Pharma and Biotech Markets – Mostly Sunny, But An Uncertain Forecast (Pharmaceutical Executive May 9, 2017)
Peter Young offers a summary of the strategic, stock market, M&A and financing issues facing the biopharma industry
Peter Young – Chemical Heritage Foundation Bolte Award (2017)
Chemical Heritage to give the Richard J. Bolte Sr. Award to Peter Young of Young & Partners on Heritage Day
In M&A, Now You See It, Now You Don’t – Young & Partners ICIS Chemical Business Feb 24, 2017 issue)
Young & Partners presents its contrarian analysis of what happened last year in global M&A and the outlook.
Chemical Financing Hits Record Levels – Young & Partners (ICIS Chemical Business Feb 17, 2017 Issue)
Young & Partners analyzes the record dollar value of debt and equity financing in chemicals
Pharma and Biotech Markets – Challenges and Opportunities (Pharma Exec January 2017 Issue)
Peter Young examines what is happening in the M&A and Equity Financing Markets and the Implications for Management
A Fireside Chat with Dr. Stephen Miller (Pharmaceutical Executive Magazine Nov 30, 2016)
Peter Young interviews Dr. Stephen Miller of Express Scripts about his career and industry thoughts
Chemical Week – M&A Moderates Despite Announced Mega Deals (November 28, 2016)
Editor-in-Chief interviews Young & Partners about M&A market slowdown and shift to Asia
Capital Markets Shift Amid Volatility (ICIS Chemical Business November 21, 2016 issue)
Young & Partners dissects the volatile debt and equity markets, including the Western IPO drought
Young & Partners 2016 Pharmaceutical Executive Summit: Steve Miller, Chief Medical Officer, Express Scripts Keynote Speech: The Evolving Role of Prescription Benefit Companies
Fireside Chat moderated by Peter Young, CEO of Young & Partners, featuring Dr. Steve Miller, Chief Medical Officer and SVP, Express Scripts Holdings Company
Creating Value in a Challenging Market (ICIS Chemical Business November 14 – 20, 2016 issue)
Young & Partners article documents the slower and shifting M&A market - contrary to conventional Wisdom
Chemical Capital Market Contradictions (ICIS Chemical Business August 15 – 21, 2016 Issue)
Young & Partners' insights about chemical company valuations, IPOs, and debt markets conditions
Chemical M&A Chaos Continues (ICIS Chemical Business August 1-14, 2016 issue)
Young & Partners reports on what happened in the first half and the outlook for 2016
Pharma and Biotech Financial Outlook – Calm or Crisis (Young & Partners Pharma Exec Article – June 2016 Issue)
Young & Partners examines whether the current slowdown in the M&A and equity financing markets a lull or permanent
Biotech Financial and M&A Trends – Two Steps Forward, One Step Back (Pharmaceutical Executive March 28, 2016)
Young & Partners examines what happened on the Biotech M&A, IPO and financial fronts in 2015 and hat to expect in 2016.
Chemical M&A finishes strong in 2015 (Interview – Chemical Week Feb. 22, 2016)
Editor-in-Chief interviews Peter Young who talks about what happened in 2015 and the deal pipeline in 2016